Private Credit Absorbed 63 Percent of Growth-Stage Debt in Q1 2026

New Yanne Capital research finds direct lenders captured 63 percent of growth-stage debt issuance in Q1 2026, up from 41 percent two years ago.

NEW YORK, NY, UNITED STATES, October 14, 2026 /EINPresswire.com/ — Private credit funds absorbed 63 percent of growth-stage debt issuance in Q1 2026, a share that stood at 41 percent as recently as Q1 2024, according to a new research paper published today by Yanne Capital. The paper argues the shift is now structural, not cyclical, and reframes how growth-stage borrowers should approach Q2 refinancing decisions.

The Bank Retreat Is Permanent, Not Cyclical

Across our advisory work in 2025 and 2026, we observe that regional and mid-market banks are no longer competing for growth-stage credit at any meaningful scale, and the founders still building their capital plans around a bank-led revolver are working from a 2022 playbook. Every debt process we have run in the past nine months has cleared with a direct lender as the anchor, with bank paper appearing only as a subordinated tranche or a working-capital sleeve.

The Federal Reserve H.4.1 series shows commercial and industrial loan balances at large domestic banks flat year-over-year through July 2026 despite nominal GDP growth of roughly 5 percent, which means real bank credit to businesses contracted. The retreat is a function of capital rules, deposit costs, and internal risk appetite, and none of those variables reverse on a Q2 timeline. Founders modeling Q2 refinancings against a return of bank pricing are mispricing their forward capital stack.

Pricing Compressed, But Structure Tightened

Our read from the deals that cleared in Q1 is that headline spreads are not where the negotiation happens anymore. Direct lender pricing on growth-stage unitranche paper landed in a tight band around SOFR plus 550 to 650 basis points through the quarter, down roughly 75 basis points from the Q3 2025 peak. That compression is real, but it obscures the more important shift, which is in covenant construction and equity cure mechanics.

The paper documents that maintenance covenant packages tightened materially in the same window that spreads compressed. Total leverage covenants set at 5.5x through 2024 are now cutting at 4.75x, and equity cure baskets that ran uncapped are now capped at two uses over the life of the facility per S&P LCD Q2 2026 comparable data. Borrowers reading the spread compression as a loosening cycle are reading half the term sheet.

The Refinancing Wall Is Real And Concentrated

We see the 2026 to 2027 refinancing calendar as the single most important variable in the growth-stage credit market for the next 18 months, and it is more concentrated than most founders realize. Bloomberg DCM data shows roughly 340 billion USD in growth-stage and lower-middle-market debt maturing between Q3 2026 and Q4 2027, with the heaviest concentration in the second and third quarters of 2027. The market has capacity to refinance this stack, but not at 2021 terms.

In the conversations we are having with borrowers 90 to 180 days from a refinancing decision, the pattern is that founders assume they will roll at flat or improved terms. Our observation from Q1 clears is that the median refinancing in the current window is closing at 100 to 175 basis points wide of the original coupon and with a tightened covenant package. Borrowers who begin the refinancing dialogue six months out are clearing meaningfully better terms than those who begin three months out.

Q2 Forward View, What The Desk Is Watching

Our forward view for Q2 rests on three variables. The first is direct lender fundraising velocity, where OECD lending standards data and PitchBook H1 2026 flows both suggest dry powder is still accumulating at the top of the market but thinning at the second-quartile funds. The second is the pace of sponsor-backed refinancings, which typically front-run non-sponsored deals into the market and set the pricing anchor. The third is the trajectory of the term SOFR curve, where Q2 forward pricing implies a modest easing that borrowers should not overweight in their base case.

The paper closes with the argument that growth-stage borrowers should be treating Q2 as a window for opportunistic action rather than a wait-and-see quarter. Facilities coming due in the first half of 2027 should be in active dialogue with lenders in September and October, not February. The refinancing calendar concentrates enough that borrowers who wait for the wave will price into it, not ahead of it.

Alex Ozdemir
Yanne Capital
+1 646-704-7533
contact@yannecapital.com
Visit us on social media:
LinkedIn

Media gallery